Variant report
Variant | esv3413133 |
---|---|
Chromosome Location | chr2:212037559-212041187 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs377271960 | chr2:212037636-212037637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546695149 | chr2:212037640-212037641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185344609 | chr2:212037650-212037651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534894593 | chr2:212037654-212037655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142282583 | chr2:212037696-212037697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73073675 | chr2:212037772-212037773 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs369800393 | chr2:212037776-212037777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368209246 | chr2:212037809-212037810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs115157487 | chr2:212037815-212037816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200717612 | chr2:212037825-212037826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373522910 | chr2:212037830-212037831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549544476 | chr2:212037848-212037849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554687947 | chr2:212037849-212037850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs386654734 | chr2:212037918-212037919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4422100 | chr2:212037928-212037929 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs373410246 | chr2:212037950-212037951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4271704 | chr2:212037952-212037953 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs374728334 | chr2:212037960-212037961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560390705 | chr2:212037989-212037990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369759321 | chr2:212038031-212038032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs4591289 | chr2:212038050-212038051 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs188845416 | chr2:212038054-212038055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs140721384 | chr2:212038101-212038102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545965182 | chr2:212038129-212038130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561203598 | chr2:212038132-212038133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200027849 | chr2:212038139-212038140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529708984 | chr2:212038156-212038157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564056735 | chr2:212038163-212038164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531436647 | chr2:212038185-212038186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2164840 | chr2:212038217-212038218 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs566480915 | chr2:212038318-212038319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6435608 | chr2:212038327-212038328 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs552007686 | chr2:212038329-212038330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571778562 | chr2:212038375-212038376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201520448 | chr2:212038427-212038428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs200523246 | chr2:212038434-212038435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs79939024 | chr2:212038435-212038436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs145748301 | chr2:212038492-212038493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548447359 | chr2:212038553-212038554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181303323 | chr2:212038560-212038561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs567666412 | chr2:212038581-212038582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs75087344 | chr2:212038654-212038655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs199644171 | chr2:212038673-212038674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1344906 | chr2:212038675-212038676 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs573159472 | chr2:212038700-212038701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545459155 | chr2:212038783-212038784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138452260 | chr2:212038784-212038785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs575383184 | chr2:212038800-212038801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200713178 | chr2:212038813-212038814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs73985165 | chr2:212038848-212038849 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 21346763 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:212037600-212039000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr2:212037800-212039000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr2:212039000-212045800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |